nodes	percent_of_prediction	percent_of_DWPC	metapath
Valganciclovir—Urethral disorder—Methotrexate—testicular cancer	0.000714	0.000714	CcSEcCtD
Valganciclovir—Weight decreased—Doxorubicin—testicular cancer	0.000713	0.000713	CcSEcCtD
Valganciclovir—Sinusitis—Epirubicin—testicular cancer	0.000713	0.000713	CcSEcCtD
Valganciclovir—Feeling abnormal—Etoposide—testicular cancer	0.000712	0.000712	CcSEcCtD
Valganciclovir—Hyperglycaemia—Doxorubicin—testicular cancer	0.000711	0.000711	CcSEcCtD
Valganciclovir—Nausea—Dactinomycin—testicular cancer	0.000709	0.000709	CcSEcCtD
Valganciclovir—Pneumonia—Doxorubicin—testicular cancer	0.000707	0.000707	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Etoposide—testicular cancer	0.000707	0.000707	CcSEcCtD
Valganciclovir—Infestation NOS—Doxorubicin—testicular cancer	0.000703	0.000703	CcSEcCtD
Valganciclovir—Infestation—Doxorubicin—testicular cancer	0.000703	0.000703	CcSEcCtD
Valganciclovir—Visual impairment—Methotrexate—testicular cancer	0.000702	0.000702	CcSEcCtD
Valganciclovir—Vomiting—Ifosfamide—testicular cancer	0.000696	0.000696	CcSEcCtD
Valganciclovir—Hypersensitivity—Cisplatin—testicular cancer	0.000695	0.000695	CcSEcCtD
Valganciclovir—Renal failure—Doxorubicin—testicular cancer	0.000691	0.000691	CcSEcCtD
Valganciclovir—Dermatitis—Ifosfamide—testicular cancer	0.000689	0.000689	CcSEcCtD
Valganciclovir—Neuropathy peripheral—Doxorubicin—testicular cancer	0.000689	0.000689	CcSEcCtD
Valganciclovir—Urticaria—Etoposide—testicular cancer	0.000687	0.000687	CcSEcCtD
Valganciclovir—Haemoglobin—Epirubicin—testicular cancer	0.000685	0.000685	CcSEcCtD
Valganciclovir—Stomatitis—Doxorubicin—testicular cancer	0.000685	0.000685	CcSEcCtD
Valganciclovir—Jaundice—Doxorubicin—testicular cancer	0.000685	0.000685	CcSEcCtD
Valganciclovir—Abdominal pain—Etoposide—testicular cancer	0.000683	0.000683	CcSEcCtD
Valganciclovir—Body temperature increased—Etoposide—testicular cancer	0.000683	0.000683	CcSEcCtD
Valganciclovir—Urinary tract infection—Doxorubicin—testicular cancer	0.000683	0.000683	CcSEcCtD
Valganciclovir—Haemorrhage—Epirubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Valganciclovir—Hepatitis—Epirubicin—testicular cancer	0.000682	0.000682	CcSEcCtD
Valganciclovir—Eye disorder—Methotrexate—testicular cancer	0.000681	0.000681	CcSEcCtD
Valganciclovir—Tinnitus—Methotrexate—testicular cancer	0.000679	0.000679	CcSEcCtD
Valganciclovir—Asthenia—Cisplatin—testicular cancer	0.000677	0.000677	CcSEcCtD
Valganciclovir—Pharyngitis—Epirubicin—testicular cancer	0.000677	0.000677	CcSEcCtD
Valganciclovir—Cardiac disorder—Methotrexate—testicular cancer	0.000676	0.000676	CcSEcCtD
Valganciclovir—Urinary tract disorder—Epirubicin—testicular cancer	0.000674	0.000674	CcSEcCtD
Valganciclovir—Oedema peripheral—Epirubicin—testicular cancer	0.000672	0.000672	CcSEcCtD
Valganciclovir—Haematuria—Doxorubicin—testicular cancer	0.00067	0.00067	CcSEcCtD
Valganciclovir—Connective tissue disorder—Epirubicin—testicular cancer	0.00067	0.00067	CcSEcCtD
Valganciclovir—Urethral disorder—Epirubicin—testicular cancer	0.000669	0.000669	CcSEcCtD
Valganciclovir—Hepatobiliary disease—Doxorubicin—testicular cancer	0.000665	0.000665	CcSEcCtD
Valganciclovir—Angiopathy—Methotrexate—testicular cancer	0.000661	0.000661	CcSEcCtD
Valganciclovir—Sinusitis—Doxorubicin—testicular cancer	0.000659	0.000659	CcSEcCtD
Valganciclovir—Immune system disorder—Methotrexate—testicular cancer	0.000658	0.000658	CcSEcCtD
Valganciclovir—Visual impairment—Epirubicin—testicular cancer	0.000657	0.000657	CcSEcCtD
Valganciclovir—Mediastinal disorder—Methotrexate—testicular cancer	0.000657	0.000657	CcSEcCtD
Valganciclovir—Chills—Methotrexate—testicular cancer	0.000654	0.000654	CcSEcCtD
Valganciclovir—Nausea—Ifosfamide—testicular cancer	0.00065	0.00065	CcSEcCtD
Valganciclovir—Diarrhoea—Cisplatin—testicular cancer	0.000646	0.000646	CcSEcCtD
Valganciclovir—Alopecia—Methotrexate—testicular cancer	0.000644	0.000644	CcSEcCtD
Valganciclovir—Mental disorder—Methotrexate—testicular cancer	0.000638	0.000638	CcSEcCtD
Valganciclovir—Eye disorder—Epirubicin—testicular cancer	0.000637	0.000637	CcSEcCtD
Valganciclovir—Hypersensitivity—Etoposide—testicular cancer	0.000637	0.000637	CcSEcCtD
Valganciclovir—Tinnitus—Epirubicin—testicular cancer	0.000636	0.000636	CcSEcCtD
Valganciclovir—Malnutrition—Methotrexate—testicular cancer	0.000634	0.000634	CcSEcCtD
Valganciclovir—Haemoglobin—Doxorubicin—testicular cancer	0.000634	0.000634	CcSEcCtD
Valganciclovir—Cardiac disorder—Epirubicin—testicular cancer	0.000633	0.000633	CcSEcCtD
Valganciclovir—Haemorrhage—Doxorubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Valganciclovir—Hepatitis—Doxorubicin—testicular cancer	0.000631	0.000631	CcSEcCtD
Valganciclovir—Pharyngitis—Doxorubicin—testicular cancer	0.000626	0.000626	CcSEcCtD
Valganciclovir—Urinary tract disorder—Doxorubicin—testicular cancer	0.000623	0.000623	CcSEcCtD
Valganciclovir—Oedema peripheral—Doxorubicin—testicular cancer	0.000622	0.000622	CcSEcCtD
Valganciclovir—Dysgeusia—Methotrexate—testicular cancer	0.000621	0.000621	CcSEcCtD
Valganciclovir—Asthenia—Etoposide—testicular cancer	0.00062	0.00062	CcSEcCtD
Valganciclovir—Connective tissue disorder—Doxorubicin—testicular cancer	0.00062	0.00062	CcSEcCtD
Valganciclovir—Angiopathy—Epirubicin—testicular cancer	0.000619	0.000619	CcSEcCtD
Valganciclovir—Urethral disorder—Doxorubicin—testicular cancer	0.000619	0.000619	CcSEcCtD
Valganciclovir—Immune system disorder—Epirubicin—testicular cancer	0.000616	0.000616	CcSEcCtD
Valganciclovir—Mediastinal disorder—Epirubicin—testicular cancer	0.000615	0.000615	CcSEcCtD
Valganciclovir—Back pain—Methotrexate—testicular cancer	0.000614	0.000614	CcSEcCtD
Valganciclovir—Chills—Epirubicin—testicular cancer	0.000612	0.000612	CcSEcCtD
Valganciclovir—Pruritus—Etoposide—testicular cancer	0.000612	0.000612	CcSEcCtD
Valganciclovir—Arrhythmia—Epirubicin—testicular cancer	0.000609	0.000609	CcSEcCtD
Valganciclovir—Visual impairment—Doxorubicin—testicular cancer	0.000608	0.000608	CcSEcCtD
Valganciclovir—Alopecia—Epirubicin—testicular cancer	0.000603	0.000603	CcSEcCtD
Valganciclovir—Vomiting—Cisplatin—testicular cancer	0.0006	0.0006	CcSEcCtD
Valganciclovir—Vision blurred—Methotrexate—testicular cancer	0.000598	0.000598	CcSEcCtD
Valganciclovir—Mental disorder—Epirubicin—testicular cancer	0.000597	0.000597	CcSEcCtD
Valganciclovir—Dermatitis—Cisplatin—testicular cancer	0.000594	0.000594	CcSEcCtD
Valganciclovir—Malnutrition—Epirubicin—testicular cancer	0.000594	0.000594	CcSEcCtD
Valganciclovir—Diarrhoea—Etoposide—testicular cancer	0.000591	0.000591	CcSEcCtD
Valganciclovir—Eye disorder—Doxorubicin—testicular cancer	0.00059	0.00059	CcSEcCtD
Valganciclovir—Ill-defined disorder—Methotrexate—testicular cancer	0.000589	0.000589	CcSEcCtD
Valganciclovir—Tinnitus—Doxorubicin—testicular cancer	0.000588	0.000588	CcSEcCtD
Valganciclovir—Anaemia—Methotrexate—testicular cancer	0.000586	0.000586	CcSEcCtD
Valganciclovir—Cardiac disorder—Doxorubicin—testicular cancer	0.000586	0.000586	CcSEcCtD
Valganciclovir—Flatulence—Epirubicin—testicular cancer	0.000585	0.000585	CcSEcCtD
Valganciclovir—Tension—Epirubicin—testicular cancer	0.000583	0.000583	CcSEcCtD
Valganciclovir—Dysgeusia—Epirubicin—testicular cancer	0.000581	0.000581	CcSEcCtD
Valganciclovir—Nervousness—Epirubicin—testicular cancer	0.000577	0.000577	CcSEcCtD
Valganciclovir—Back pain—Epirubicin—testicular cancer	0.000574	0.000574	CcSEcCtD
Valganciclovir—Angiopathy—Doxorubicin—testicular cancer	0.000573	0.000573	CcSEcCtD
Valganciclovir—Malaise—Methotrexate—testicular cancer	0.000572	0.000572	CcSEcCtD
Valganciclovir—Dizziness—Etoposide—testicular cancer	0.000572	0.000572	CcSEcCtD
Valganciclovir—Muscle spasms—Epirubicin—testicular cancer	0.000571	0.000571	CcSEcCtD
Valganciclovir—Immune system disorder—Doxorubicin—testicular cancer	0.00057	0.00057	CcSEcCtD
Valganciclovir—Vertigo—Methotrexate—testicular cancer	0.00057	0.00057	CcSEcCtD
Valganciclovir—Mediastinal disorder—Doxorubicin—testicular cancer	0.000569	0.000569	CcSEcCtD
Valganciclovir—Leukopenia—Methotrexate—testicular cancer	0.000568	0.000568	CcSEcCtD
Valganciclovir—Chills—Doxorubicin—testicular cancer	0.000566	0.000566	CcSEcCtD
Valganciclovir—Arrhythmia—Doxorubicin—testicular cancer	0.000564	0.000564	CcSEcCtD
Valganciclovir—Nausea—Cisplatin—testicular cancer	0.00056	0.00056	CcSEcCtD
Valganciclovir—Vision blurred—Epirubicin—testicular cancer	0.00056	0.00056	CcSEcCtD
Valganciclovir—Alopecia—Doxorubicin—testicular cancer	0.000558	0.000558	CcSEcCtD
Valganciclovir—Cough—Methotrexate—testicular cancer	0.000554	0.000554	CcSEcCtD
Valganciclovir—Mental disorder—Doxorubicin—testicular cancer	0.000553	0.000553	CcSEcCtD
Valganciclovir—Ill-defined disorder—Epirubicin—testicular cancer	0.000551	0.000551	CcSEcCtD
Valganciclovir—Convulsion—Methotrexate—testicular cancer	0.00055	0.00055	CcSEcCtD
Valganciclovir—Vomiting—Etoposide—testicular cancer	0.00055	0.00055	CcSEcCtD
Valganciclovir—Malnutrition—Doxorubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Valganciclovir—Anaemia—Epirubicin—testicular cancer	0.000549	0.000549	CcSEcCtD
Valganciclovir—Agitation—Epirubicin—testicular cancer	0.000546	0.000546	CcSEcCtD
Valganciclovir—Dermatitis—Etoposide—testicular cancer	0.000545	0.000545	CcSEcCtD
Valganciclovir—Headache—Etoposide—testicular cancer	0.000542	0.000542	CcSEcCtD
Valganciclovir—Flatulence—Doxorubicin—testicular cancer	0.000541	0.000541	CcSEcCtD
Valganciclovir—Arthralgia—Methotrexate—testicular cancer	0.00054	0.00054	CcSEcCtD
Valganciclovir—Tension—Doxorubicin—testicular cancer	0.000539	0.000539	CcSEcCtD
Valganciclovir—Dysgeusia—Doxorubicin—testicular cancer	0.000538	0.000538	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000536	0.000536	CcSEcCtD
Valganciclovir—Malaise—Epirubicin—testicular cancer	0.000535	0.000535	CcSEcCtD
Valganciclovir—Discomfort—Methotrexate—testicular cancer	0.000534	0.000534	CcSEcCtD
Valganciclovir—Nervousness—Doxorubicin—testicular cancer	0.000534	0.000534	CcSEcCtD
Valganciclovir—Vertigo—Epirubicin—testicular cancer	0.000533	0.000533	CcSEcCtD
Valganciclovir—Leukopenia—Epirubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Valganciclovir—Back pain—Doxorubicin—testicular cancer	0.000531	0.000531	CcSEcCtD
Valganciclovir—Muscle spasms—Doxorubicin—testicular cancer	0.000528	0.000528	CcSEcCtD
Valganciclovir—Confusional state—Methotrexate—testicular cancer	0.000522	0.000522	CcSEcCtD
Valganciclovir—Cough—Epirubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Valganciclovir—Anaphylactic shock—Methotrexate—testicular cancer	0.000518	0.000518	CcSEcCtD
Valganciclovir—Vision blurred—Doxorubicin—testicular cancer	0.000518	0.000518	CcSEcCtD
Valganciclovir—Convulsion—Epirubicin—testicular cancer	0.000514	0.000514	CcSEcCtD
Valganciclovir—Infection—Methotrexate—testicular cancer	0.000514	0.000514	CcSEcCtD
Valganciclovir—Nausea—Etoposide—testicular cancer	0.000513	0.000513	CcSEcCtD
Valganciclovir—Hypertension—Epirubicin—testicular cancer	0.000513	0.000513	CcSEcCtD
Valganciclovir—Ill-defined disorder—Doxorubicin—testicular cancer	0.00051	0.00051	CcSEcCtD
Valganciclovir—Nervous system disorder—Methotrexate—testicular cancer	0.000508	0.000508	CcSEcCtD
Valganciclovir—Anaemia—Doxorubicin—testicular cancer	0.000508	0.000508	CcSEcCtD
Valganciclovir—Thrombocytopenia—Methotrexate—testicular cancer	0.000507	0.000507	CcSEcCtD
Valganciclovir—Arthralgia—Epirubicin—testicular cancer	0.000505	0.000505	CcSEcCtD
Valganciclovir—Agitation—Doxorubicin—testicular cancer	0.000505	0.000505	CcSEcCtD
Valganciclovir—Anxiety—Epirubicin—testicular cancer	0.000504	0.000504	CcSEcCtD
Valganciclovir—Skin disorder—Methotrexate—testicular cancer	0.000503	0.000503	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.000502	0.000502	CcSEcCtD
Valganciclovir—Hyperhidrosis—Methotrexate—testicular cancer	0.000501	0.000501	CcSEcCtD
Valganciclovir—Discomfort—Epirubicin—testicular cancer	0.000499	0.000499	CcSEcCtD
Valganciclovir—Malaise—Doxorubicin—testicular cancer	0.000495	0.000495	CcSEcCtD
Valganciclovir—Dry mouth—Epirubicin—testicular cancer	0.000494	0.000494	CcSEcCtD
Valganciclovir—Vertigo—Doxorubicin—testicular cancer	0.000494	0.000494	CcSEcCtD
Valganciclovir—Anorexia—Methotrexate—testicular cancer	0.000494	0.000494	CcSEcCtD
Valganciclovir—Leukopenia—Doxorubicin—testicular cancer	0.000492	0.000492	CcSEcCtD
Valganciclovir—Confusional state—Epirubicin—testicular cancer	0.000489	0.000489	CcSEcCtD
Valganciclovir—Anaphylactic shock—Epirubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Valganciclovir—Oedema—Epirubicin—testicular cancer	0.000485	0.000485	CcSEcCtD
Valganciclovir—Hypotension—Methotrexate—testicular cancer	0.000484	0.000484	CcSEcCtD
Valganciclovir—Infection—Epirubicin—testicular cancer	0.000481	0.000481	CcSEcCtD
Valganciclovir—Cough—Doxorubicin—testicular cancer	0.000479	0.000479	CcSEcCtD
Valganciclovir—Convulsion—Doxorubicin—testicular cancer	0.000476	0.000476	CcSEcCtD
Valganciclovir—Nervous system disorder—Epirubicin—testicular cancer	0.000475	0.000475	CcSEcCtD
Valganciclovir—Thrombocytopenia—Epirubicin—testicular cancer	0.000474	0.000474	CcSEcCtD
Valganciclovir—Hypertension—Doxorubicin—testicular cancer	0.000474	0.000474	CcSEcCtD
Valganciclovir—Tachycardia—Epirubicin—testicular cancer	0.000473	0.000473	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.000472	0.000472	CcSEcCtD
Valganciclovir—Skin disorder—Epirubicin—testicular cancer	0.000471	0.000471	CcSEcCtD
Valganciclovir—Hyperhidrosis—Epirubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Valganciclovir—Insomnia—Methotrexate—testicular cancer	0.000468	0.000468	CcSEcCtD
Valganciclovir—Arthralgia—Doxorubicin—testicular cancer	0.000468	0.000468	CcSEcCtD
Valganciclovir—Anxiety—Doxorubicin—testicular cancer	0.000466	0.000466	CcSEcCtD
Valganciclovir—Paraesthesia—Methotrexate—testicular cancer	0.000465	0.000465	CcSEcCtD
Valganciclovir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000464	0.000464	CcSEcCtD
Valganciclovir—Discomfort—Doxorubicin—testicular cancer	0.000462	0.000462	CcSEcCtD
Valganciclovir—Anorexia—Epirubicin—testicular cancer	0.000462	0.000462	CcSEcCtD
Valganciclovir—Dyspnoea—Methotrexate—testicular cancer	0.000462	0.000462	CcSEcCtD
Valganciclovir—Somnolence—Methotrexate—testicular cancer	0.00046	0.00046	CcSEcCtD
Valganciclovir—Dry mouth—Doxorubicin—testicular cancer	0.000457	0.000457	CcSEcCtD
Valganciclovir—Dyspepsia—Methotrexate—testicular cancer	0.000456	0.000456	CcSEcCtD
Valganciclovir—Hypotension—Epirubicin—testicular cancer	0.000453	0.000453	CcSEcCtD
Valganciclovir—Confusional state—Doxorubicin—testicular cancer	0.000452	0.000452	CcSEcCtD
Valganciclovir—Decreased appetite—Methotrexate—testicular cancer	0.00045	0.00045	CcSEcCtD
Valganciclovir—Oedema—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Valganciclovir—Anaphylactic shock—Doxorubicin—testicular cancer	0.000448	0.000448	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000447	0.000447	CcSEcCtD
Valganciclovir—Fatigue—Methotrexate—testicular cancer	0.000446	0.000446	CcSEcCtD
Valganciclovir—Infection—Doxorubicin—testicular cancer	0.000445	0.000445	CcSEcCtD
Valganciclovir—Pain—Methotrexate—testicular cancer	0.000443	0.000443	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000441	0.000441	CcSEcCtD
Valganciclovir—Nervous system disorder—Doxorubicin—testicular cancer	0.00044	0.00044	CcSEcCtD
Valganciclovir—Thrombocytopenia—Doxorubicin—testicular cancer	0.000439	0.000439	CcSEcCtD
Valganciclovir—Insomnia—Epirubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Valganciclovir—Tachycardia—Doxorubicin—testicular cancer	0.000438	0.000438	CcSEcCtD
Valganciclovir—Skin disorder—Doxorubicin—testicular cancer	0.000435	0.000435	CcSEcCtD
Valganciclovir—Paraesthesia—Epirubicin—testicular cancer	0.000435	0.000435	CcSEcCtD
Valganciclovir—Hyperhidrosis—Doxorubicin—testicular cancer	0.000433	0.000433	CcSEcCtD
Valganciclovir—Dyspnoea—Epirubicin—testicular cancer	0.000432	0.000432	CcSEcCtD
Valganciclovir—Somnolence—Epirubicin—testicular cancer	0.000431	0.000431	CcSEcCtD
Valganciclovir—Anorexia—Doxorubicin—testicular cancer	0.000427	0.000427	CcSEcCtD
Valganciclovir—Feeling abnormal—Methotrexate—testicular cancer	0.000427	0.000427	CcSEcCtD
Valganciclovir—Dyspepsia—Epirubicin—testicular cancer	0.000427	0.000427	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Methotrexate—testicular cancer	0.000423	0.000423	CcSEcCtD
Valganciclovir—Decreased appetite—Epirubicin—testicular cancer	0.000421	0.000421	CcSEcCtD
Valganciclovir—Hypotension—Doxorubicin—testicular cancer	0.000419	0.000419	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000418	0.000418	CcSEcCtD
Valganciclovir—Fatigue—Epirubicin—testicular cancer	0.000418	0.000418	CcSEcCtD
Valganciclovir—Constipation—Epirubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Valganciclovir—Pain—Epirubicin—testicular cancer	0.000414	0.000414	CcSEcCtD
Valganciclovir—Urticaria—Methotrexate—testicular cancer	0.000411	0.000411	CcSEcCtD
Valganciclovir—Body temperature increased—Methotrexate—testicular cancer	0.000409	0.000409	CcSEcCtD
Valganciclovir—Abdominal pain—Methotrexate—testicular cancer	0.000409	0.000409	CcSEcCtD
Valganciclovir—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000408	0.000408	CcSEcCtD
Valganciclovir—Insomnia—Doxorubicin—testicular cancer	0.000405	0.000405	CcSEcCtD
Valganciclovir—Paraesthesia—Doxorubicin—testicular cancer	0.000403	0.000403	CcSEcCtD
Valganciclovir—Dyspnoea—Doxorubicin—testicular cancer	0.0004	0.0004	CcSEcCtD
Valganciclovir—Feeling abnormal—Epirubicin—testicular cancer	0.000399	0.000399	CcSEcCtD
Valganciclovir—Somnolence—Doxorubicin—testicular cancer	0.000399	0.000399	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Epirubicin—testicular cancer	0.000396	0.000396	CcSEcCtD
Valganciclovir—Dyspepsia—Doxorubicin—testicular cancer	0.000395	0.000395	CcSEcCtD
Valganciclovir—Decreased appetite—Doxorubicin—testicular cancer	0.00039	0.00039	CcSEcCtD
Valganciclovir—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000387	0.000387	CcSEcCtD
Valganciclovir—Fatigue—Doxorubicin—testicular cancer	0.000387	0.000387	CcSEcCtD
Valganciclovir—Urticaria—Epirubicin—testicular cancer	0.000385	0.000385	CcSEcCtD
Valganciclovir—Constipation—Doxorubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Valganciclovir—Pain—Doxorubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Valganciclovir—Body temperature increased—Epirubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Valganciclovir—Abdominal pain—Epirubicin—testicular cancer	0.000383	0.000383	CcSEcCtD
Valganciclovir—Hypersensitivity—Methotrexate—testicular cancer	0.000381	0.000381	CcSEcCtD
Valganciclovir—Asthenia—Methotrexate—testicular cancer	0.000371	0.000371	CcSEcCtD
Valganciclovir—Feeling abnormal—Doxorubicin—testicular cancer	0.000369	0.000369	CcSEcCtD
Valganciclovir—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000367	0.000367	CcSEcCtD
Valganciclovir—Pruritus—Methotrexate—testicular cancer	0.000366	0.000366	CcSEcCtD
Valganciclovir—Hypersensitivity—Epirubicin—testicular cancer	0.000357	0.000357	CcSEcCtD
Valganciclovir—Urticaria—Doxorubicin—testicular cancer	0.000356	0.000356	CcSEcCtD
Valganciclovir—Abdominal pain—Doxorubicin—testicular cancer	0.000354	0.000354	CcSEcCtD
Valganciclovir—Body temperature increased—Doxorubicin—testicular cancer	0.000354	0.000354	CcSEcCtD
Valganciclovir—Diarrhoea—Methotrexate—testicular cancer	0.000354	0.000354	CcSEcCtD
Valganciclovir—Asthenia—Epirubicin—testicular cancer	0.000348	0.000348	CcSEcCtD
Valganciclovir—Pruritus—Epirubicin—testicular cancer	0.000343	0.000343	CcSEcCtD
Valganciclovir—Dizziness—Methotrexate—testicular cancer	0.000342	0.000342	CcSEcCtD
Valganciclovir—Diarrhoea—Epirubicin—testicular cancer	0.000332	0.000332	CcSEcCtD
Valganciclovir—Hypersensitivity—Doxorubicin—testicular cancer	0.00033	0.00033	CcSEcCtD
Valganciclovir—Vomiting—Methotrexate—testicular cancer	0.000329	0.000329	CcSEcCtD
Valganciclovir—Dermatitis—Methotrexate—testicular cancer	0.000326	0.000326	CcSEcCtD
Valganciclovir—Headache—Methotrexate—testicular cancer	0.000324	0.000324	CcSEcCtD
Valganciclovir—Asthenia—Doxorubicin—testicular cancer	0.000322	0.000322	CcSEcCtD
Valganciclovir—Dizziness—Epirubicin—testicular cancer	0.00032	0.00032	CcSEcCtD
Valganciclovir—Pruritus—Doxorubicin—testicular cancer	0.000317	0.000317	CcSEcCtD
Valganciclovir—Vomiting—Epirubicin—testicular cancer	0.000308	0.000308	CcSEcCtD
Valganciclovir—Nausea—Methotrexate—testicular cancer	0.000308	0.000308	CcSEcCtD
Valganciclovir—Diarrhoea—Doxorubicin—testicular cancer	0.000307	0.000307	CcSEcCtD
Valganciclovir—Dermatitis—Epirubicin—testicular cancer	0.000305	0.000305	CcSEcCtD
Valganciclovir—Headache—Epirubicin—testicular cancer	0.000304	0.000304	CcSEcCtD
Valganciclovir—Dizziness—Doxorubicin—testicular cancer	0.000296	0.000296	CcSEcCtD
Valganciclovir—Nausea—Epirubicin—testicular cancer	0.000288	0.000288	CcSEcCtD
Valganciclovir—Vomiting—Doxorubicin—testicular cancer	0.000285	0.000285	CcSEcCtD
Valganciclovir—Dermatitis—Doxorubicin—testicular cancer	0.000282	0.000282	CcSEcCtD
Valganciclovir—Headache—Doxorubicin—testicular cancer	0.000281	0.000281	CcSEcCtD
Valganciclovir—Nausea—Doxorubicin—testicular cancer	0.000266	0.000266	CcSEcCtD
